Barings’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-752
| Closed | -$363K | – | 231 |
|
|
2022
Q2 | $363K | Sell |
752
-52
| -6% | -$25.7K | 0.01% | 228 |
|
|
2022
Q1 | $395K | Hold |
804
| – | – | 0.01% | 221 |
|
|
2021
Q4 | $373K | Sell |
804
-74
| -8% | -$31.1K | 0.01% | 281 |
|
|
2021
Q3 | $328K | Sell |
878
-441
| -33% | -$168K | 0.01% | 299 |
|
|
2021
Q2 | $503K | Sell |
1,319
-120
| -8% | -$45.9K | 0.01% | 287 |
|
|
2021
Q1 | $517K | Sell |
1,439
-475
| -25% | -$153K | 0.01% | 300 |
|
|
2020
Q4 | $614K | Sell |
1,914
-7,956
| -81% | -$2.44M | 0.02% | 276 |
|
|
2020
Q3 | $2.65M | Buy |
9,870
+328
| +3% | +$88.3K | 0.06% | 205 |
|
|
2020
Q2 | $2.17M | Hold |
9,542
| – | – | 0.07% | 184 |
|
|
2020
Q1 | $2.17M | Sell |
9,542
-738
| -7% | -$201K | 0.07% | 184 |
|
|
2019
Q4 | $3.1M | Buy |
10,280
+9,354
| +1,010% | +$2.57M | 0.08% | 190 |
|
|
2019
Q3 | $223K | Buy |
926
+6
| +0.7% | +$1.64K | 0.01% | 614 |
|
|
2019
Q2 | $259K | Sell |
920
-5,267
| -85% | -$1.44M | 0.01% | 608 |
|
|
2019
Q1 | $1.77M | Sell |
6,187
-3,050
| -33% | -$882K | 0.04% | 301 |
|
|
2018
Q4 | $2.43M | Sell |
9,237
-230
| -2% | -$63.2K | 0.04% | 224 |
|
|
2018
Q3 | $2.6M | Hold |
9,467
| – | – | 0.04% | 291 |
|
|
2018
Q2 | $2.25M | Sell |
9,467
-1,587
| -14% | -$368K | 0.03% | 327 |
|
|
2018
Q1 | $2.43M | Hold |
11,054
| – | – | 0.03% | 330 |
|
|
2017
Q4 | $2.49M | Hold |
11,054
| – | – | 0.03% | 337 |
|
|
2017
Q3 | $2.1M | Hold |
11,054
| – | – | 0.04% | 307 |
|
|
2017
Q2 | $2.08M | Sell |
11,054
-4,970
| -31% | -$893K | 0.06% | 298 |
|
|
2017
Q1 | $2.65M | Hold |
16,024
| – | – | 0.05% | 289 |
|
|
2016
Q4 | $2.3M | Sell |
16,024
-5,880
| -27% | -$787K | 0.06% | 247 |
|
|
2016
Q3 | $2.75M | Sell |
21,904
-35,680
| -62% | -$4.61M | 0.07% | 204 |
|
|
2016
Q2 | $7.56M | Hold |
57,584
| – | – | 0.2% | 62 |
|
|
2016
Q1 | $8M | Sell |
57,584
-1,140
| -2% | -$152K | 0.21% | 58 |
|
|
2015
Q4 | $8.19M | Sell |
58,724
-9,050
| -13% | -$1.25M | 0.2% | 58 |
|
|
2015
Q3 | $9.49M | Sell |
67,774
-4,180
| -6% | -$628K | 0.23% | 53 |
|
|
2015
Q2 | $11.8M | Buy |
71,954
+7,830
| +12% | +$1.25M | 0.36% | 48 |
|
|
2015
Q1 | $9.9M | Sell |
64,124
-2,070
| -3% | -$295K | 0.23% | 57 |
|
|
2014
Q4 | $8.32M | Buy |
66,194
+1,100
| +2% | +$136K | 0.18% | 74 |
|
|
2014
Q3 | $7.79M | Sell |
65,094
-22,530
| -26% | -$2.58M | 0.17% | 85 |
|
|
2014
Q2 | $9.43M | Buy |
87,624
+14,210
| +19% | +$1.46M | 0.28% | 68 |
|
|
2014
Q1 | $7.31M | Buy |
73,414
+3,200
| +5% | +$289K | 0.23% | 88 |
|
|
2013
Q4 | $6.49M | Buy |
70,214
+6,400
| +10% | +$569K | 0.27% | 79 |
|
|
2013
Q3 | $5.33M | Buy |
63,814
+9,300
| +17% | +$797K | 0.23% | 96 |
|
|
2013
Q2 | $4.46M | Buy |
+54,514
| New | +$4.08M | 0.2% | 103 |
|
Other funds holding ELV
Barings's ELV Position: Q3 2022 in Review
Barings sold out of Elevance Health (ELV) in Q3 2022, closing a stake of 752 shares — an estimated $363K sold.
Barings first reported a position in ELV in Q2 2013 and held it in 37 quarters. The position peaked at $11.8M in Q2 2015. 1,447 funds tracked by Wall St. Rank hold ELV as of Q3 2022.
- Barings reported no remaining Elevance Health position as of Q3 2022 after selling out during the quarter.
- Barings sold 752 Elevance Health shares in Q3 2022, an estimated $363K.
- Barings first reported a position in Elevance Health in Q2 2013 and held it in 37 quarters.
- Barings's Elevance Health position peaked at $11.8M in Q2 2015.
- 1,447 funds tracked by Wall St. Rank held Elevance Health as of Q3 2022.
Based on Barings's 13F filing for Q3 2022, filed 14 Nov 2022.